What Happens in Mounjaro Week 5 — and What Most People Get Wrong

The biggest myth: if weight loss slows at week 5, the medicine isn't working

This is the question our prescribers hear most often around this point in treatment. A plateau or slowdown in the fifth week does not mean tirzepatide has stopped working. What it usually means is that the dose has just changed.

The standard Mounjaro titration moves patients from 2.5mg to 5mg at around week 5. The 2.5mg pen was never designed to drive significant weight loss — its job was to let your system adjust to the medicine. The 5mg dose is where appetite suppression begins to deepen meaningfully for most people, but the body needs a few weeks at the new level before that effect is fully established.

Weight loss across the SURMOUNT-1 trial (which followed over 2,500 adults with obesity across 72 weeks) was not linear. Participants lost weight in a staggered pattern that reflected dose increases, not a smooth downward line. Expecting steady weekly losses at this stage misreads how tirzepatide actually works. If you are not seeing movement on the scales right now, that is not the story the next few weeks will tell. You can read about how results develop further on in our Mounjaro week-by-week guide.

If after six months at the highest tolerated dose weight loss is less than 5%, that is when a prescriber would formally review whether continuing is appropriate, as noted in NICE's appraisal of tirzepatide (TA1026). Week 5 is nowhere near that threshold.

Side effects at week 5: the dose-increase effect and what to do about it

If nausea, loose stools or indigestion had quietened down over weeks 3 and 4, do not be surprised if they return briefly after the step up to 5mg. This is a pattern that repeats with each dose increase and is caused by tirzepatide's effect on gastric emptying, food moves more slowly through the stomach, and a higher dose amplifies that temporarily.

A practical detail that makes a real difference: taking your weekly injection at a consistent time and keeping the pen stored correctly in the fridge door (between 2°C and 8°C, per the Patient Information Leaflet) removes one variable from the equation. Injection timing consistency matters too; our page on the best day of the week to take Mounjaro covers this.

The NHS tirzepatide medicines page lists the most common side effects: nausea, diarrhoea, constipation, vomiting, indigestion, stomach pain, and injection-site reactions. Most are gastrointestinal and most settle as the body acclimates to each new dose. Eating smaller portions, slowly, and avoiding fatty or spicy meals in the 24 hours around injection day tends to reduce the severity.

Seek urgent medical attention for severe or persistent stomach pain that radiates to the back, with or without vomiting, this can indicate pancreatitis, which the MHRA flagged in January 2026 as a known but uncommon risk with GLP-1 medicines. Rare, but worth knowing. If you have concerns about any specific symptom, the right place to direct them is your prescriber, not a forum.

No weight loss at week 5: when to act and when to wait

A dedicated page covers this in full, but the short answer is: week 5 is too early to draw conclusions, and the dose increase itself can temporarily disrupt weight trends as the body responds to new demands on digestion and appetite regulation.

What is worth paying attention to at this stage is not the scale number but the appetite signals. Most people at week 5 on Mounjaro report that portion sizes are noticeably smaller, the urge to snack has reduced, and the mental noise around food has quietened. Those are signs the medicine is working as intended, even if the number on the scale has moved less than expected this particular week.

If there has been genuinely no change in appetite, no change in eating patterns, and no weight change at all across multiple weeks, that is a conversation to have with your prescriber. Our guide to no weight loss at week 5 on Mounjaro covers the specific scenarios and what they typically mean.

It is also worth keeping the broader context in mind. The SURMOUNT-1 trial data shows average reductions of around 20% at 15mg over 72 weeks, not at five weeks. Longer-term outcomes are explored further in our tirzepatide overview.

How to get the most from week 5 onward

There is no complex protocol required. Protein at each meal, adequate water, and some form of movement most days are the consistent recommendations alongside GLP-1 treatment. Protein matters particularly because reduced appetite can lead to eating less of everything, including the nutrients that preserve muscle mass.

Week 5 is also a reasonable point to check that your setup is right from a service perspective. If you are on Mounjaro through a private provider, your notes from week 5 onward should be part of a clinical record, not just an app with no human behind it. Our clinical team reviews every repeat order before it is dispensed, and prescribers are available to discuss dose-increase decisions.

Cost is sometimes a concern at the point of moving to 5mg, since higher doses carry higher list prices. Our Mounjaro cost page sets out how UK private pricing works and what legitimate providers include in the price. What comes next is covered in our Mounjaro week 6 guide.

If you are considering starting treatment and want to understand what week 5 would look like for you specifically, the right first step is a clinical assessment. Check your eligibility with our prescribers, the consultation is free, and a real clinician reads your answers the same day.